Sale!

RRM2B Gene Mitochondrial DNA Depletion Syndrome 8B MNGIE Type Genetic Test

Original price was: $700.Current price is: $500.

-29%

The RRM2B Gene Mitochondrial DNA Depletion Syndrome 8B MNGIE Type NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the RRM2B gene responsible for mitochondrial DNA depletion syndrome type 8B. This specialized test utilizes next-generation sequencing (NGS) technology to detect genetic abnormalities that disrupt mitochondrial function, leading to severe neurological complications. The test is essential for individuals experiencing symptoms like gastrointestinal dysmotility, peripheral neuropathy, ophthalmoplegia, or leukoencephalopathy. By providing accurate genetic diagnosis, this test enables targeted treatment approaches and informed family planning decisions. Available for $500 USD, our comprehensive testing includes pre-test genetic counseling and detailed result interpretation by expert genetic specialists.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

RRM2B Gene Mitochondrial DNA Depletion Syndrome 8B MNGIE Type NGS Genetic DNA Test

Comprehensive Genetic Testing for Mitochondrial Disorders

The RRM2B Gene Mitochondrial DNA Depletion Syndrome 8B MNGIE Type NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for rare mitochondrial disorders. This advanced genetic test specifically targets the RRM2B gene, which plays a crucial role in maintaining mitochondrial DNA integrity and cellular energy production. Mitochondrial DNA depletion syndromes are severe genetic conditions characterized by reduced mitochondrial DNA copy numbers in affected tissues, leading to progressive multi-system dysfunction.

What Does This Test Measure?

This specialized NGS-based genetic test comprehensively analyzes the RRM2B gene to identify pathogenic variants associated with Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE) type syndrome. The test detects:

  • Point mutations, insertions, and deletions in the RRM2B gene
  • Variants affecting mitochondrial nucleotide pool balance
  • Genetic alterations that disrupt mitochondrial DNA replication
  • Mutations leading to impaired deoxyribonucleotide synthesis

Who Should Consider This Test?

This genetic test is recommended for individuals presenting with clinical features suggestive of mitochondrial DNA depletion syndrome, particularly:

Clinical Indications and Symptoms

  • Progressive gastrointestinal dysmotility and pseudo-obstruction
  • Peripheral neuropathy with sensory and motor involvement
  • Chronic progressive external ophthalmoplegia
  • Leukoencephalopathy visible on brain MRI
  • Severe gastrointestinal symptoms with weight loss
  • Family history of mitochondrial disorders
  • Unexplained neurological deterioration in childhood or adulthood
  • Multi-system involvement affecting neurological and gastrointestinal systems

Benefits of RRM2B Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous clinical advantages:

Diagnostic Clarity and Precision

  • Provides definitive molecular diagnosis for complex neurological conditions
  • Differentiates between various mitochondrial disorder subtypes
  • Enables targeted therapeutic interventions and management strategies
  • Facilitates accurate prognosis assessment and disease monitoring

Family Planning and Genetic Counseling

  • Identifies carrier status for at-risk family members
  • Supports informed reproductive decision-making
  • Enables prenatal diagnosis and preimplantation genetic testing
  • Provides basis for comprehensive genetic counseling services

Understanding Your Test Results

Our expert genetic specialists provide comprehensive interpretation of your RRM2B gene analysis results:

Positive Result Interpretation

A positive result indicates the presence of pathogenic variants in the RRM2B gene, confirming the diagnosis of Mitochondrial DNA Depletion Syndrome 8B. This finding enables:

  • Implementation of targeted symptomatic management
  • Specialized neurological and gastrointestinal care planning
  • Family member screening and genetic counseling
  • Access to specialized mitochondrial disorder resources

Negative Result Interpretation

A negative result suggests that RRM2B gene mutations are not the cause of the clinical symptoms. This may indicate:

  • Need for additional genetic testing for other mitochondrial genes
  • Consideration of alternative neurological diagnoses
  • Continued clinical monitoring and evaluation
  • Potential involvement of other genetic or environmental factors

Test Pricing and Details

Test Component Price (USD)
Discount Price $500
Regular Price $700
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Nationwide Testing Availability

We have diagnostic centers conveniently located across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about mitochondrial disorders affect your quality of life. Our comprehensive RRM2B genetic testing provides the answers you need for proper diagnosis and management. Our team of board-certified genetic counselors and neurologists are ready to guide you through the testing process and help interpret your results.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your RRM2B Gene Mitochondrial DNA Depletion Syndrome 8B MNGIE Type NGS Genetic DNA Test. Take control of your genetic health with confidence and expert medical support.